Skip to main content
Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
0.852
-0.020 (-2.30%)
At close: Dec 5, 2025, 4:00 PM EST
0.843
-0.009 (-1.10%)
After-hours: Dec 5, 2025, 7:31 PM EST

Equillium Revenue

Equillium had revenue of $4.39M in the twelve months ending September 30, 2025, down -90.43% year-over-year. In the year 2024, Equillium had annual revenue of $41.10M with 13.89% growth.

Revenue (ttm)
$4.39M
Revenue Growth
-90.43%
P/S Ratio
8.37
Revenue / Employee
$125,486
Employees
35
Market Cap
51.91M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202441.10M5.01M13.89%
Dec 31, 202336.08M20.33M128.97%
Dec 31, 202215.76M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 435.16B
Johnson & Johnson 92.15B
Merck & Co. 64.24B
AbbVie 59.64B
Eli Lilly and Company 59.42B
AstraZeneca 58.13B
Novartis AG 56.37B
Novo Nordisk 49.58B
Revenue Rankings

EQ News

More News